Literature DB >> 15643506

Keratinocyte growth factor receptor expression in normal colorectal epithelial cells and differentiated type of colorectal cancer.

Masanori Yoshino1, Toshiyuki Ishiwata, Masanori Watanabe, Osamu Komine, Tetsuo Shibuya, Akira Tokunaga, Zenya Naito.   

Abstract

The keratinocyte growth factor receptor, also known as KGFR/FGFR2 IIIb, is mainly localized in epithelial cells and participates in the proliferation of these cells. In the present study, we attempted to clarify the expression and role of KGFR in human colorectal cancer. The KGFR protein was detected in several colorectal cancer cell lines. Immuno-histochemically, KGFR was expressed on the luminal surface of epithelial cells in normal colorectal tissues. KGFR was expressed in 35 of 56 (62.5%) colorectal cancer patients and localized at the center of the cancer nests. Cytokeratin 20 (CK 20) colocalized with KGFR. In contrast, Ki-67 localized at the periphery of the cancer nests. Clinicopathologically, a high level of KGFR expression was associated with well-differentiated histological type (p<0.0001) and shallow wall invasion (p<0.0174). These findings indicate that KGFR may play important roles in the differentiation of normal colorectal epithelial cells and establishment of the well-differentiated histological type of colorectal cancer cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15643506

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  Synthesis and in vivo evaluation of N-ethylamino-2-oxo-1,2-dihydro-quinoline-3-carboxamide for inhibition of intestinal tumorigenesis in APC(Min/+) mice.

Authors:  Gopal Pathuri; Qian Li; Altaf Mohammed; Hariprasad Gali; J Thomas Pento; Chinthalapally V Rao
Journal:  Bioorg Med Chem Lett       Date:  2014-01-27       Impact factor: 2.823

2.  Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas.

Authors:  Qi Zhao; Otavia L Caballero; Ian D Davis; Eric Jonasch; Pheroze Tamboli; W K Alfred Yung; John N Weinstein; Robert L Strausberg; Jun Yao
Journal:  Clin Cancer Res       Date:  2013-02-26       Impact factor: 12.531

Review 3.  Predictive and prognostic biomarkers with therapeutic targets in advanced colorectal cancer.

Authors:  Hui-Yan Luo; Rui-Hua Xu
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

4.  Fibroblast growth factor 7 signalling is disrupted in colorectal cancer and is a potential marker of field cancerisation.

Authors:  Abhilasha Patel; Gyanendra Tripathi; Philip McTernan; Kishore Gopalakrishnan; Omar Ali; Emma Spector; Nigel Williams; Ramesh P Arasaradnam
Journal:  J Gastrointest Oncol       Date:  2019-06

Review 5.  2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology.

Authors:  Richard J Epstein; Li Jun Tian; Yan Fei Gu
Journal:  J Oncol       Date:  2021-04-30       Impact factor: 4.375

6.  Fibroblast growth factor receptor 2: expression, roles, and potential as a novel molecular target for colorectal cancer.

Authors:  Yoko Matsuda; Junji Ueda; Toshiyuki Ishiwata
Journal:  Patholog Res Int       Date:  2012-06-04

7.  Epithelial expression of keratinocytes growth factor in oral precancer lesions.

Authors:  Sudha Jimson; S Murali; Susan L Zunt; Lawrence I Goldblatt; Mythily Srinivasan
Journal:  Dent Res J (Isfahan)       Date:  2016 May-Jun

8.  In vitro and in vivo evaluation of the radiosensitizing effect of a selective FGFR inhibitor (JNJ-42756493) for rectal cancer.

Authors:  Maud Verstraete; Annelies Debucquoy; Annelies Gonnissen; Ruveyda Dok; Sofie Isebaert; Ellen Devos; William McBride; Karin Haustermans
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.